1 |
Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics[J]. Clin Rev Allergy Immunol, 2021, 61 (2): 194-211.
|
2 |
Thiam HR, Wong SL, Wagner DD, et al. Cellular mechanisms of NETosis[J]. Annu Rev Cell Dev Biol, 2020 (36): 191-218.
|
3 |
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135 (17): e927-e999.
|
4 |
Kang JM, Jung J, Kim YE, et al. Temporal correlation between Kawasaki disease and infectious diseases in South Korea[J]. JAMA Netw Open, 2022, 5 (2): e2147363.
|
5 |
Min DE, Kim DH, Han MY, et al. High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease[J]. Korean J Pediatr, 2019, 62 (6): 235-239.
|
6 |
Root-Bernstein R. From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem inflammatory syndrome in children[J]. Int J Mol Sci, 2023, 24 (3): 3001.
|
7 |
张巧梅,孙小平,李冠胜,等.针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J/CD].中华危重症医学杂志(电子版),2023,16(4):265-271.
|
8 |
Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism[J]. Circ Res, 2021, 128 (12): 2017-2036.
|
9 |
Chen KD, Huang YH, Wu WS, et al. Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19[J]. Front Immunol, 2022 (13): 995886.
|
10 |
Szturmowicz M, Demkow U. Neutrophil extracellular traps (NETs) in severe SARS-CoV-2 lung disease[J]. Int J Mol Sci, 2021, 22 (16): 8854.
|
11 |
Mao JY, Zhang JH, Cheng W, et al. Effects of neutrophil extracellular traps in patients with septic coagulopathy and their interaction with autophagy[J]. Front Immunol, 2021 (12): 757041.
|
12 |
Hu J, Qian W, Wang T, et al. Neutrophil extracellular traps formation and citrullinated histones 3 levels in patients with Kawasaki disease[J]. Iran J Immunol, 2023, 3 (20): 327-334.
|
13 |
Orekhov AN, Poznyak AV, Sobenin IA, et al. Mitochondrion as a selective target for the treatment of atherosclerosis: role of mitochondrial DNA mutations and defective mitophagy in the pathogenesis of atherosclerosis and chronic inflammation[J]. Curr Neuropharmacol, 2020, 18 (11): 1064-1075.
|
14 |
杨雪剑,饶昊杰,陈虹,等.中性粒细胞胞外诱捕网在血栓形成中作用的研究进展[J].中国分子心脏病学杂志,2023,23(3):5462-5467.
|
15 |
Menikou S, Langford PR, Levin M. Kawasaki disease: the role of immune complexes revisited[J]. Front Immunol, 2019 (10): 1156.
|
16 |
Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models[J]. Nat Rev Rheumatol, 2020, 16 (7): 391-405.
|
17 |
Wang L, Luqmani R, Udalova IA. The role of neutrophils in rheumatic disease-associated vascular inflammation[J]. Nat Rev Rheumatol, 2022, 18 (3): 158-170.
|
18 |
Islam MM, Takeyama N. Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances[J]. Int J Mol Sci, 2023, 24 (21): 15805.
|
19 |
Blanco LP, Wang X, Carlucci PM, et al. RNA externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells[J]. Arthritis Rheumatol, 2021, 73 (12): 2282-2292.
|
20 |
Thiam HR, Wong SL, Qiu R, et al. NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin decondensation and nuclear envelope rupture[J]. Proc Natl Acad Sci U S A, 2020, 117 (13): 7326-7337.
|
21 |
Shiratori-Aso S, Nakazawa D. The involvement of NETs in ANCA-associated vasculitis[J]. Front Immunol, 2023 (14): 1261151.
|
22 |
Beckley MA, Shrestha S, Singh KK, et al. The role of mitochondria in the pathogenesis of Kawasaki disease[J]. Front Immunol, 2022 (13): 1017401.
|
23 |
Marek-Iannucci S, Ozdemir AB, Moreira D, et al. Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis[J]. JCI Insight, 2021, 6 (18): e151981.
|
24 |
Bonaventura A, Vecchié A, Abbate A, et al. Neutrophil extracellular traps and cardiovascular diseases: an update[J]. Cells, 2020, 9 (1): 231.
|
25 |
Brown GD,Willment JA, Whitehead L. C-type lectinsin immunity and homeostasis[J]. Nat Rev Immunol, 2018, 18 (6): 374-389.
|
26 |
Liew PX, Kubes P. The neutrophil's role during health and disease[J]. Physiol Rev, 2019, 99 (2): 1223-1248.
|
27 |
Masso-Silva JA, Sakoulas G, Olay J, et al. Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin[J]. Front Immunol, 2022 (13): 993720.
|
28 |
Bohlander F, Riehl D, Weiβmüller S, et al. Immunomodulation: immunoglobulin preparations suppress hyper inflammation in a COVID-19 model via FcγRⅡ A and FcαRⅠ[J]. Front Immunol, 2021 (12): 700429.
|